<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="72292">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02164591</url>
  </required_header>
  <id_info>
    <org_study_id>Temp GES</org_study_id>
    <nct_id>NCT02164591</nct_id>
  </id_info>
  <brief_title>Escalating Temporary Gastric Electrical Stimulation (GES) for Severe Gastroparesis</brief_title>
  <acronym>TempGES</acronym>
  <official_title>Escalating Temporary Gastric Electrical Stimulation for Severe Gastroparesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indiana University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the physiologic effects of temporary gastric
      electrical stimulation in subjects with severe gastroparesis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will look to determine the clinical benefit placing temporary gastric electrical
      stimulation, the ability to predict the clinical response to surgical implantation of GES,
      and the feasibility and patient tolerability of endoscopic placement of temporary Gastric
      Electrical Stimulator (t-GES),
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in the symptoms of gastroparesis by t-GES in patients with severe gastroparesis.</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical response to t-GES placement as measured by questionnaires</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Develop a prospective registry in patients undergoing escalating t-GES</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>determine the feasibility and patient tolerability of endoscopic placement of t-GES</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Gastroparesis</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum to be frozen
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects who have been diagnosed with gatroparesis.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  At least 3 months of gastroparesis-related symptoms, such as nausea, emesis, and/or
             retching

          -  Solid phase 4-hr gastric scintigraphy is consistent with gastroparesis within 3
             months of study enrollment*

               -  retention at 2 hr: &gt;60% or

               -  retention at 4 hr: &gt;10% *Based on International consensus on gastric
                  scintigraphy

        Exclusion Criteria:

          -  Gastric outlet, small bowel, or colon obstruction.

          -  Small bowel malrotation

          -  Inflammatory bowel disease

          -  Contraindication for surgical implantation of GES

          -  Presence of illness that may require MRI during the study; such as pituitary tumor,
             herniated disc, spinal stenosis, multiple sclerosis, etc.

          -  Significant comorbidity due to sever cardiovascular, renal, pulmonary, or liver
             disease.

          -  Significant coagulopathy

          -  Non-ambulatory patients: bed-ridden, nursing home resident, etc.

          -  Pregnancy

          -  Unable to give own informed consent

          -  Prisoners
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John M Wo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anita Gupta, MBBS, MPH</last_name>
    <phone>317-948-9227</phone>
    <email>anigupta@iu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Miranda Williams</last_name>
    <email>mw39@iu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Indiana University Hosptial</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anita Gupta, MBBS, MPH</last_name>
      <phone>317-948-9227</phone>
      <email>anigupta@iu.edu</email>
    </contact>
    <investigator>
      <last_name>Thomas Nowak, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Attila Nekeeb, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joel Wittles, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <lastchanged_date>July 16, 2016</lastchanged_date>
  <firstreceived_date>June 6, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indiana University</investigator_affiliation>
    <investigator_full_name>John Wo, MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>gastroparesis</keyword>
  <keyword>gastric electrical stimulator</keyword>
  <keyword>GES</keyword>
  <keyword>vomiting</keyword>
  <keyword>nausea</keyword>
  <keyword>bloating</keyword>
  <keyword>postprandial fullness</keyword>
  <keyword>epigastric pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Gastroparesis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
